刊物主题:Biomedicine Cancer Research Pharmacology and Toxicology Oncology
出版者:Springer Berlin / Heidelberg
ISSN:1432-0843
卷排序:78
文摘
PurposeThe relationship between plasma concentration and antitumor activity of gefitinib was assessed in patients with advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations.